ACM
IMNN icon

Altium Capital Management’s Imunon IMNN Stock Holding History

Altium Capital Management’s Portfolio IMNN Stock Details IMNN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-17,869
Closed -$4.83M – 144
2021
Q1 		$4.83M Buy
+17,869
New +$6M 1.34% 24

Other funds holding IMNN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EP
Eudaimonia Partners Winchester, Tennessee $420M AUM 27.21% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Altium Capital Management's IMNN Position: Q2 2021 in Review

Altium Capital Management sold out of Imunon (IMNN) in Q2 2021, closing a stake of 17,869 shares — an estimated $4.83M sold.

Altium Capital Management first reported a position in IMNN in Q1 2021 and held it in 1 quarter. The position peaked at $4.83M in Q1 2021. 37 funds tracked by Wall St. Rank hold IMNN as of Q2 2021.

  • Altium Capital Management reported no remaining Imunon position as of Q2 2021 after selling out during the quarter.
  • Altium Capital Management sold 17,869 Imunon shares in Q2 2021, an estimated $4.83M.
  • Altium Capital Management first reported a position in Imunon in Q1 2021 and held it in 1 quarter.
  • Altium Capital Management's Imunon position peaked at $4.83M in Q1 2021.
  • 37 funds tracked by Wall St. Rank held Imunon as of Q2 2021.

Based on Altium Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.